← Leaderboards

Rebecca M Baron

Brigham And Women'S Hospital

Google Scholar ↗PubMed ↗ORCID ↗

$10,418,078

Attributed

$14,611,768

Total exposure

8

Grants

6

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY2005–23

$2.5M$1.9M$1.3M$625K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$14,611,768 · 8

By mechanism

R01$8,604,125 · 4

R33$3,249,318 · 1

P01$1,794,697 · 1

K08$621,000 · 1

R21$342,628 · 1

Top collaborators

Most similar at Brigham And Women'S Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Sepsis”

Ian A Wilson · Scripps Research Institute, The$50,300,809
Vance G Fowler · Duke University$48,391,331
Alon Singer · Helixbind, Inc.$39,385,728
Henry F Chambers · Duke University$39,317,414
Jonathan Michael Dean · University Of Utah$36,397,260
Rama K Mallampalli · Ohio State University$23,779,171

Research focus

SepsisLung InjuryResponsePlasmaCritical IllnessAdult Respiratory Distress SyndromeCellsPlayInflammatoryLungEnrollmentInfectionCytokineMortality Vital StatisticsReportingPathway InteractionsBiological MarkersSamplingNovel TherapeuticsResearch PersonnelIn VivoInflammationRegulationSyndrome

Grant awards (31)

A Phase 1b Study of Inhaled CO for the Treatment of Sepsis-Induced ARDS$1,604,157

R33 · FY2023 · HL

A Phase 1b Study of Inhaled CO for the Treatment of Sepsis-Induced ARDS$1,645,161

R33 · FY2022 · HL

Therapeutic modulation of zinc for lung injury and mechanobiology$689,461

R01 · FY2022 · HL · contact PI

Therapeutic modulation of zinc for lung injury and mechanobiology$691,901

R01 · FY2021 · HL · contact PI

Therapeutic modulation of zinc for lung injury and mechanobiology$694,308

R01 · FY2020 · HL · contact PI

Biomarkers of Interstitial Lung Abnormalities Predict Poor Outcomes in ARDS.$169,858

R21 · FY2020 · HL · contact PI

Therapeutic modulation of zinc for lung injury and mechanobiology$765,335

R01 · FY2019 · HL · contact PI

Biomarkers of Interstitial Lung Abnormalities Predict Poor Outcomes in ARDS.$172,770

R21 · FY2019 · HL · contact PI

MicroRNA-181b and Sepsis$455,739

R01 · FY2018 · GM

MicroRNA-181b and Sepsis$455,739

R01 · FY2017 · GM

MicroRNA-181b and Sepsis$462,750

R01 · FY2016 · GM

MicroRNA-181b and Sepsis$462,537

R01 · FY2015 · GM

The Inflammasome: A Novel Biomarker in ALI/ARDS$433,348

R01 · FY2015 · HL · contact PI

Clinical Studies Coordination Core$366,644

P01 · FY2015 · HL · contact PI

The Inflammasome: A Novel Biomarker in ALI/ARDS$438,105

R01 · FY2014 · HL · contact PI

Clinical Studies Coordination Core$366,718

P01 · FY2014 · HL · contact PI

The Inflammasome: A Novel Biomarker in ALI/ARDS$439,053

R01 · FY2013 · HL · contact PI

Role of NOS2 in Sepsis-Induced ARDS$415,728

R01 · FY2013 · HL · contact PI

Clinical Studies Coordination Core$362,258

P01 · FY2013 · HL · contact PI

The Inflammasome: A Novel Biomarker in ALI/ARDS$460,292

R01 · FY2012 · HL

Role of NOS2 in Sepsis-Induced ARDS$436,689

R01 · FY2012 · HL · contact PI

Clinical Studies Coordination Core$332,960

P01 · FY2012 · HL · contact PI

Role of NOS2 in Sepsis-Induced ARDS$441,100

R01 · FY2011 · HL · contact PI

Clinical Studies Coordination Core$366,117

P01 · FY2011 · HL · contact PI

Role of NOS2 in Sepsis-Induced ARDS$441,100

R01 · FY2010 · HL · contact PI

Role of NOS2 in Sepsis-Induced ARDS$420,940

R01 · FY2009 · HL · contact PI

HMG-1/Y Regulation of NOS2 Expression in Endotoxemia$128,520

K08 · FY2007 · AI · contact PI

HMG-1/Y Regulation of NOS2 Expression in Endotoxemia$128,520

K08 · FY2006 · AI · contact PI

HMG-1/Y Regulation of NOS2 Expression in Endotoxemia$128,520

K08 · FY2005 · AI

HMG-1/Y Regulation of NOS2 Expression in Endotoxemia$117,720

K08 · FY2004 · AI

HMG-1/Y Regulation of NOS2 Expression in Endotoxemia$117,720

K08 · FY2003 · AI